Table 3.

Relationship between % BMD increase and T-score change in the TH and LS at 1 yr after treatment with romosozumab or alendronate.

	Romosozumab (n = 1739)		Alendronate (n = 1726)
	Mean % change BMD	Mean change T-score	Mean % change BMD	Mean change T-score
Total hip	6.3%	0.31	2.9%	0.15
Lumbar spine	13.9%	0.90	5.1%	0.34

Adapted from reference 33.